Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigma Diagnostics was a prominent clinical diagnostics business, originally a division of the life science giant Sigma-Aldrich, specializing in in vitro diagnostic (IVD) reagents and systems. The company was a major player in the clinical chemistry, coagulation, and hematology markets, providing high-quality testing kits to hospital and reference laboratories worldwide. In 2000, the business was acquired by Trinity Biotech for approximately $51 million, which integrated Sigma's extensive product line into its own diagnostics portfolio. This acquisition allowed Trinity Biotech to significantly expand its presence in the United States and global diagnostics markets. Today, the legacy of Sigma Diagnostics lives on through the continued production and sale of its reagents under the Trinity Biotech brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sigma Diagnostics.